Related references
Note: Only part of the references are listed.Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures
Christina Small et al.
BMC NEPHROLOGY (2017)
Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy
Caitlin McIntyre et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Predialysis Cardiovascular Disease Medication Adherence and Mortality After Transition to Dialysis
Miklos Z. Molnar et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD
Talar Markossian et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Remembering Statins: Do Statins Have Adverse Cognitive Effects?
Rafael Bitzur
DIABETES CARE (2016)
Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness A Randomized Clinical Trial
Jean S. Kutner et al.
JAMA INTERNAL MEDICINE (2015)
Contrasting Cholesterol Management Guidelines for Adults with CKD
Lisandro D. Colantonio et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
ESRD Care Within the US Department of Veterans Affairs: A Forward-Looking Program With an Illuminating Past
Suzanne Watnick et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process
Emily Reeve et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy-A meta-analysis of 11 randomized controlled trials involving 21,295 participants
Marcin Barylski et al.
PHARMACOLOGICAL RESEARCH (2013)
Lipid-Lowering Therapy in Persons With Chronic Kidney Disease A Systematic Review and Meta-analysis
Ashish Upadhyay et al.
ANNALS OF INTERNAL MEDICINE (2012)
IMPORTANCE OF HEALTH SYSTEM CONTEXT FOR EVALUATING UTILIZATION PATTERNS ACROSS SYSTEMS
James F. Burgess et al.
HEALTH ECONOMICS (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients
Yi-Wen Chiu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients
Franz Wiesbauer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
Giovanni F. M. Strippoli et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
